As fragment of a collaboration with 23andMe,the personalized medicine company Celmatix is looking to dramatically improve the diagnosis and treatment of infertility.
Infertility affects a large portion of the population, with an estimated one in eight couples in the United States having difficulty conceiving. There are many reasons for that — couples waiting longer to...
Read more
Source: 23andme.com